ProCE Banner Activity

The Role of the Hematology Pharmacist in CP-CML: Brief Overview on Individualizing Frontline Therapy, Risk Assessment, and Monitoring

Slideset

Access these slides to learn what hematology pharmacists need to know about treatment goals, risk assessment, and optimal frontline CP-CML treatment in practice.

Released: April 23, 2025

Expiration: October 22, 2025

Share

Provided by

Provided by ProCE LLC. in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Clinical Care Options, LLC

ProCE Banner